PEAK6
TDOC icon

PEAK6’s Teladoc Health TDOC Stock Holding History

PEAK6’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-62,717
Closed -$417K – 3211
2026
Q1 		$342K Sell
62,717
-6,033
-9% -$33.9K ﹤0.01% 2115
2025
Q4 		$481K Buy
+68,750
New +$538K ﹤0.01% 2115

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

PEAK6's TDOC Position: Q2 2026 in Review

PEAK6 sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 62,717 shares — an estimated $417K sold.

PEAK6 first reported a position in TDOC in Q4 2025 and held it in 2 quarters. The position peaked at $481K in Q4 2025. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • PEAK6 reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
  • PEAK6 sold 62,717 Teladoc Health shares in Q2 2026, an estimated $417K.
  • PEAK6 first reported a position in Teladoc Health in Q4 2025 and held it in 2 quarters.
  • PEAK6's Teladoc Health position peaked at $481K in Q4 2025.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.